Patient Characteristics Associated With Chemotherapy-Induced Peripheral Neuropathy Severity in a Phase II Clinical Trial: A Retrospective Analysis

INTRODUCTION: Chemotherapy-induced peripheral neuropathy (CIPN) can lead to chemotherapy dose reduction, delay, and discontinuation, and has limited effective prevention strategies. Our study aimed to identify patient characteristics associated with CIPN severity during weekly paclitaxel chemotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhi, Wanqing Iris, Dreyfus, Nechama, Lessing, Alexie, Galantino, Marylou, Piulson, Lauren, Kot, Kevin Liu, Li, Susan, Bao, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Breast Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322124/
https://www.ncbi.nlm.nih.gov/pubmed/36972359
http://dx.doi.org/10.1093/oncolo/oyad062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322124/
https://www.ncbi.nlm.nih.gov/pubmed/36972359
http://dx.doi.org/10.1093/oncolo/oyad062

Ejemplares similares